Cencora, Inc. (NYSE:COR) CAO Sells $520,120.00 in Stock

Cencora, Inc. (NYSE:COR - Get Free Report) CAO Lazarus Krikorian sold 2,000 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $260.06, for a total transaction of $520,120.00. Following the transaction, the chief accounting officer now directly owns 20,154 shares of the company's stock, valued at $5,241,249.24. The trade was a 9.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Cencora Price Performance

NYSE:COR traded down $0.69 during mid-day trading on Tuesday, reaching $260.87. 2,532,540 shares of the stock were exchanged, compared to its average volume of 1,353,283. The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 16.40. The business has a fifty day moving average price of $245.08 and a 200 day moving average price of $238.54. Cencora, Inc. has a 1-year low of $214.77 and a 1-year high of $262.93. The firm has a market capitalization of $50.59 billion, a PE ratio of 37.11, a PEG ratio of 1.31 and a beta of 0.51.

Cencora (NYSE:COR - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $3.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.50 by $0.23. Cencora had a net margin of 0.46% and a return on equity of 328.62%. Research analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Friday, February 14th were issued a $0.55 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $2.20 annualized dividend and a dividend yield of 0.84%. Cencora's dividend payout ratio is currently 31.29%.

Analyst Upgrades and Downgrades

COR has been the topic of a number of recent analyst reports. StockNews.com cut Cencora from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Wells Fargo & Company lifted their target price on Cencora from $237.00 to $251.00 and gave the company an "equal weight" rating in a research note on Wednesday, January 29th. JPMorgan Chase & Co. increased their price target on Cencora from $289.00 to $301.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Mizuho started coverage on Cencora in a report on Wednesday, December 4th. They set an "outperform" rating and a $280.00 price target on the stock. Finally, Evercore ISI upped their price objective on shares of Cencora from $270.00 to $280.00 and gave the stock an "outperform" rating in a report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $277.90.

Remove Ads

Institutional Investors Weigh In On Cencora

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Wood Tarver Financial Group LLC acquired a new stake in shares of Cencora during the fourth quarter worth $136,000. Siemens Fonds Invest GmbH raised its holdings in Cencora by 944.6% during the 4th quarter. Siemens Fonds Invest GmbH now owns 19,972 shares of the company's stock worth $4,645,000 after buying an additional 18,060 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Cencora during the 4th quarter worth about $38,652,000. Azzad Asset Management Inc. ADV lifted its stake in Cencora by 34.5% during the fourth quarter. Azzad Asset Management Inc. ADV now owns 10,905 shares of the company's stock valued at $2,450,000 after buying an additional 2,800 shares in the last quarter. Finally, Jefferies Financial Group Inc. boosted its holdings in shares of Cencora by 61.6% in the fourth quarter. Jefferies Financial Group Inc. now owns 9,375 shares of the company's stock worth $2,106,000 after buying an additional 3,574 shares during the period. Institutional investors and hedge funds own 97.52% of the company's stock.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.